These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 28666544)

  • 61. Molecular biology of Alzheimer's dementia and its clinical relevance to early diagnosis and new therapeutic strategies.
    Wiltfang J; Esselmann H; Maler JM; Bleich S; Hüther G; Kornhuber J
    Gerontology; 2001; 47(2):65-71. PubMed ID: 11287729
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Nanotechnology and the diagnosis of dermatological infectious disease.
    Blecher Paz K; Friedman A
    J Drugs Dermatol; 2012 Jul; 11(7):846-51. PubMed ID: 22777227
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease.
    Kulkarni PV; Roney CA; Antich PP; Bonte FJ; Raghu AV; Aminabhavi TM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(1):35-47. PubMed ID: 20049829
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Chapter 5 - Development of iron chelator-nanoparticle conjugates as potential therapeutic agents for Alzheimer disease.
    Liu G; Men P; Perry G; Smith MA
    Prog Brain Res; 2009; 180():97-108. PubMed ID: 20302830
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Alzheimer's disease. AMA Council on Scientific Affairs Reference Committee D.
    J Okla State Med Assoc; 1998 Aug; 91(5):298-306. PubMed ID: 9714972
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Determinants of the quality of life in Alzheimer's disease patients as assessed by the Japanese version of the Quality of Life-Alzheimer's disease scale.
    Matsui T; Nakaaki S; Murata Y; Sato J; Shinagawa Y; Tatsumi H; Furukawa TA
    Dement Geriatr Cogn Disord; 2006; 21(3):182-91. PubMed ID: 16401890
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Unraveling the mechanistic complexity of Alzheimer's disease through systems biology.
    Rollo JL; Banihashemi N; Vafaee F; Crawford JW; Kuncic Z; Holsinger RM
    Alzheimers Dement; 2016 Jun; 12(6):708-18. PubMed ID: 26703952
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Commentary on "Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease." A Canadian perspective.
    Gauthier S; Patterson C; Gordon M; Soucy JP; Schubert F; Leuzy A
    Alzheimers Dement; 2011 May; 7(3):330-2. PubMed ID: 21575874
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Recent Trends in Nanotechnology Toward CNS Diseases: Lipid-Based Nanoparticles and Exosomes for Targeted Therapeutic Delivery.
    Cardoso AM; Guedes JR; Cardoso AL; Morais C; Cunha P; Viegas AT; Costa R; Jurado A; Pedroso de Lima MC
    Int Rev Neurobiol; 2016; 130():1-40. PubMed ID: 27678173
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Alzheimer's disease and nursing. New scientific and clinical insights.
    Yi ES; Abraham IL; Holroyd S
    Nurs Clin North Am; 1994 Mar; 29(1):85-99. PubMed ID: 8121829
    [TBL] [Abstract][Full Text] [Related]  

  • 71. White paper on expanding the role of pharmacists in caring for individuals with Alzheimer's disease: APhA Foundation Coordinating Council to Improve Collaboration in Supporting Patients with Alzheimer's Disease.
    Skelton JB
    J Am Pharm Assoc (2003); 2008; 48(6):715-21. PubMed ID: 19019799
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Translation of Pre-Clinical Studies into Successful Clinical Trials for Alzheimer's Disease: What are the Roadblocks and How Can They Be Overcome?
    Banik A; Brown RE; Bamburg J; Lahiri DK; Khurana D; Friedland RP; Chen W; Ding Y; Mudher A; Padjen AL; Mukaetova-Ladinska E; Ihara M; Srivastava S; Padma Srivastava MV; Masters CL; Kalaria RN; Anand A
    J Alzheimers Dis; 2015; 47(4):815-43. PubMed ID: 26401762
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mapping the road forward in Alzheimer's disease.
    Holtzman DM; Goate A; Kelly J; Sperling R
    Sci Transl Med; 2011 Dec; 3(114):114ps48. PubMed ID: 22190237
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Alzheimer's Disease Diagnostics Must Be Globally Accessible.
    Clute-Reinig N; Jayadev S; Rhoads K; Le Ny AL
    J Alzheimers Dis; 2021; 84(4):1453-1455. PubMed ID: 34690142
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A life-course and multifactorial approach to Alzheimer's disease: Implications for research, clinical assessment and intervention practices.
    Van der Linden M; Juillerat Van der Linden AC
    Dementia (London); 2018 Oct; 17(7):880-895. PubMed ID: 27353414
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [The Use of Artificial Intelligence in Alzheimer's Disease - Personalized Diagnostics and Therapy].
    Wiltfang J; Esselmann H; Barnikol UB
    Psychiatr Prax; 2021 Mar; 48(S 01):S31-S36. PubMed ID: 33652485
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Emerging Advances in Nanotheranostics with Intelligent Bioresponsive Systems.
    Wang J; Tao W; Chen X; Farokhzad OC; Liu G
    Theranostics; 2017; 7(16):3915-3919. PubMed ID: 29109787
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Alzheimer's Disease-Biochemical and Psychological Background for Diagnosis and Treatment.
    Beata BK; Wojciech J; Johannes K; Piotr L; Barbara M
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674580
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Challenges for Alzheimer's Disease Therapy: Insights from Novel Mechanisms Beyond Memory Defects.
    Frozza RL; Lourenco MV; De Felice FG
    Front Neurosci; 2018; 12():37. PubMed ID: 29467605
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Editorial: From Current Diagnostic Tools and Therapeutics for Alzheimer's Disease Towards Earlier Diagnostic Markers and Treatment Targets.
    Krantic S
    Curr Alzheimer Res; 2017; 14(1):2-5. PubMed ID: 28088908
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.